Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
What you need to know about flu treatments as cases spike across the US - 2Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- 3Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods
- 4Katz alleges Army Radio workers misled High Court in bid to halt closure
- 5The Way to Recuperation: Defeating Dependence
- Which Startup's Innovation Could Reform Medical care?
- Sean Penn lights up, Kylie Jenner gets A-list approval and 7 other moments you didn’t see at the Golden Globes
- Investigating the Financial History of the World: A Succinct Outline
- International issues on the agenda as Frances's Macron visits China
- 'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
- Most loved Web-based feature: Which Stage Do You Like
- Scientists find twisting magnetic waves on the sun. Could this help solve a huge solar mystery?
- Radiate brilliantly: The 5 Precious stone Rings to Purchase in 2024
- Newly discovered link between traumatic brain injury in children and epigenetic changes could help personalize treatment for recovering kids
